Atorvastatin Clinical Trials

4 actively recruiting trials across 1 location

▼ -1 trial since June 2026

Also known as: Lipitor

Pipeline

Phase 2: 1Phase 3: 2Phase 4: 1

Top Sponsors

Tampere University Hospital1
National Institute on Deafness and Other Communication Disorders (NIDCD)1
Gustave Roussy, Cancer Campus, Grand Paris1
Beijing Tsinghua Chang Gung Hospital1

Indications

Cancer3
Prostate Cancer2
Prediabetic State (IGT)1
Metastatic Renal Cancer1
Metastatic Kidney Cancer1

Other3 trials

Measuring Oncological Value of Exercise and Statin

Phase 3

The Effects of Xuezhikang and Atorvastatin on Lipid in Patients With Dyslipidemia and Prediabetes

Phase 4

Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer

Phase 3

Atlanta, Georgia1 trial

Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer

Winship Cancer Institute at Emory University

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.